GS3-05: Evaluation of the Sensitivity to Endocrine Therapy (SETER/PR) assay to predict benefit from extended endocrine therapy in the NRG/NSABP B-42 trial Author: Eleftherios P Mamounas, AdventHealth ...
Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression Fig 1. Cancer care multiteam system. A specialized ...
This study is looking at changes to the liver and the immune system which could help diagnose liver cancer at an early stage. It is for people who have either: cancer of the liver, bile duct and ...
HOUSTON, Nov. 4, 2025 /PRNewswire/ -- Delphi Diagnostics announces the upcoming presentation of four scientific abstracts, including one platform presentation highlighting new clinical data supporting ...
Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression Identifying nontechnical, teamwork competencies (knowledge ...
a long term condition affecting either the liver, bile duct or gallbladder which is not cancer but increases the risk of cancer in the future The study is part of a larger research programme called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results